Skip to main content
SleepCited

Restless Legs Syndrome: Neurochemistry and Therapy.

David Anguizola, Alba Garcia Aragón, Brian Moncada, Diego Garcia-Borreguero
Review Seminars in neurology 2025
PubMed DOI
<\/script>\n
`; }, get iframeSnippet() { const domain = 'sleepcited.com'; const params = 'pmid\u003D40068886'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

Study Design

Loại nghiên cứu
Review
Đối tượng nghiên cứu
Patients with restless legs syndrome
Can thiệp
Restless Legs Syndrome: Neurochemistry and Therapy. None
Đối chứng
None
Kết quả chính
None
Xu hướng hiệu quả
Mixed
Nguy cơ sai lệch
Unclear

Abstract

Restless legs syndrome (RLS) is a complex sensorimotor disorder characterized by disturbances in key neurochemical pathways, including dopaminergic, glutamatergic, and adenosinergic systems. This review provides an overview of the current knowledge on RLS, including its clinical features and diagnosis, pathophysiology, and treatment (non-pharmacological and pharmacological). We examine the association between RLS and neurological disorders, genetic predispositions, and brain iron deficiency. Emerging therapies targeting glutamate and adenosine receptors, alongside established dopamine agonists and α2δ ligands, offer promising avenues for treatment.

Used In Evidence Reviews

Similar Papers